GlassScriptPhysician profile
Anna Mantikas
NPI 1689326845
$808.99
in general payments reported to CMS, 2019-2025
9 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $342 · 2024: $169 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $206.10 | 2023 | Surgx, Blastx, Xperience |
| Kerecis Limited | $141.93 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Hydrofera LLC | $99.25 | 2023 | Hydrofera Blue |
| Solventum Corporation | $87.25 | 2024-2025 | Activ.A.C., V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Smith+Nephew, INC. | $85.40 | 2023-2025 | Collagenase Santyl |
| Tactile Systems Technology INC | $63.21 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Abbvie INC. | $55.74 | 2024-2025 | |
| Convatec INC. | $51.26 | 2024-2025 | |
| Urgo Medical North America, LLC | $18.85 | 2025 | Urgoclean Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Mantikas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.